(Q1 Un-audited): As per life revenue account of the company for January to March, 2026, excess of total income over total expenses including claims (surplus) was BDT 112.83 million as against excess of total income over total expenses including claims (surplus) of BDT 283.79 million in the corresponding previous period of 2025. Balance of Life Insurance Fund was BDT 9,072.30 million as on March 31, 2026 as against BDT 8,336.01 million as on March 31, 2025 resulting a net increase of BDT 736.29 million. (end)

The Board of Directors has recommended 0.25% Cash Dividend excluding Sponsors and Directors for the year ended June 30, 2025. The Sponsors and Directors hold 19,418,373 shares of the company and Cash Dividend payable to the General Shareholders is Tk. 1,132,226.73. Date, Time, Venue of AGM and Record Date will be notified later subject to consent accorded from the honorable High Court. The Company has also reported EPS of Tk. (3.17), NAV per share of Tk. 18.46 and NOCFPS of Tk. 0.70 for the year ended June 30, 2025 as against Tk. (0.12), Tk. 21.73 and Tk. 4.21 respectively for the year ended June 30, 2024. (end)

The Board of Directors has recommended 15% Cash Dividend for the year ended December 31, 2025. Date of AGM: August 27, 2026, at 10.00 A.M., Venue: (Hybrid System) Conference Room (5th Floor) SLICL, 68/B, DIT Road, Malibagh Chowdhury Para. Record Date: August 02, 2026. The Company has also reported EPS of Tk. 1.62, NAV per share of Tk. 32.15 and NOCFPS of Tk. 11.81 for the year ended December 31, 2025 as against Tk. 1.73, Tk. 39.64 and Tk. 17.37 respectively for the year ended December 31, 2024.

(Q2 Un-audited): EPS was Tk. 0.55 for April-June 2026 as against Tk. 0.56 for April-June 2025; EPS was Tk. 1.24 for January-June 2026 as against Tk. 1.23 for January-June 2025. NOCFPS was Tk. 0.52 for January-June 2026 as against Tk. 0.66 for January-June 2025. NAV per share was Tk. 22.05 as on June 30, 2026 and Tk. 20.16 as on June 30, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 13, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2025.

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 12.07.2026 to 13.07.2026 and trading of the shares will remain suspended on record date i.e., 14.07.2026.